Ultragenyx Pharmaceutical, Inc. (RARE)

23.50 -0.38 (-1.59%) USD  |  NASDAQ  |  Feb 12, 16:00
23.24 -0.26 (-1.11%) After-Hours: 05:56
More

Ultragenyx Pharmaceutical EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. --
Insmed, Inc. --
Apellis Pharmaceuticals, Inc. --